Publicis Groupe SA
F:PU4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Publicis Groupe SA
F:PU4
|
FR |
|
V
|
Vertex Pharmaceuticals Inc
XMUN:VX1
|
US |
|
F
|
Factset Research Systems Inc
XMUN:FA1
|
US |
|
JPMorgan Chase & Co
F:CMC
|
US |
|
P
|
Perusahaan Gas Negara Tbk PT
SWB:PGB1
|
ID |
|
H
|
Harmony Gold Mining Company Ltd
XMUN:HAM1
|
ZA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PU4's stock price target?
Price Target
112.97
EUR
According to Wall Street analysts, the average 1-year price target for 
PU4 is 112.97 EUR with a low forecast of 91.52 EUR and a high forecast of 126.86 EUR.
What is the Revenue forecast for Publicis Groupe SA?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 0%.
What is the Operating Income forecast for Publicis Groupe SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 8 years is 5%.
What is the Pre-Tax Income forecast for Publicis Groupe SA?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Publicis Groupe SA?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 8 years is 7%.